Adverse Effects of Combined Tyrosine Kinase Inhibitors

被引：0
|
作者：
Lu, Shun [1 ]
Li, Ziming [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai Lung Canc Ctr, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2020年 / 15卷 / 11期
关键词：
INTERSTITIAL LUNG-DISEASE; CANCER; C797S; GEFITINIB; T790M;
D O I：
10.1016/j.jtho.2020.07.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E182 / E183
页数：2
相关论文
共 50 条
  • [41] A Mini-Review on EGFR-Tyrosine Kinase Inhibitors and their Resistance Mechanisms
    Naim, Mohd. Javed
    Samad, Abdul
    CURRENT PHARMACEUTICAL DESIGN, 2025,
  • [42] Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment
    Paul W. Sylvester
    Genes & Nutrition, 2012, 7 : 63 - 74
  • [43] Have adjuvant tyrosine kinase inhibitors lost their shine?
    Sabari, Joshua K.
    Chaft, Jamie E.
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (15)
  • [44] Transport of six tyrosine kinase inhibitors: active or passive?
    Honeywell, Richard J.
    Hitzerd, Sarina
    Kathmann, Letje
    Peters, Godefridus J.
    ADMET AND DMPK, 2016, 4 (01): : 23 - 34
  • [45] New tyrosine kinase and EGFR inhibitors in cancer therapy
    Rottlaender, D.
    Reda, S.
    Motloch, L. J.
    Hoppe, U. C.
    INTERNIST, 2011, 52 (10): : 1245 - +
  • [46] EGFR Tyrosine Kinase Inhibitors: Difference in Efficacy and Resistance
    Kyle W. Robinson
    Alan B. Sandler
    Current Oncology Reports, 2013, 15 : 396 - 404
  • [47] Tyrosine kinase inhibitors and atherosclerosis: A close but complicated relationship
    Xu, Ke
    Tang, Hao
    Xiong, Jie
    Ban, Xiaofang
    Duan, Yuchen
    Tu, Yingfeng
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 954
  • [48] Advances in studies of tyrosine kinase inhibitors and their acquired resistance
    Qinlian Jiao
    Lei Bi
    Yidan Ren
    Shuliang Song
    Qin Wang
    Yun-shan Wang
    Molecular Cancer, 17
  • [49] Advances in studies of tyrosine kinase inhibitors and their acquired resistance
    Jiao, Qinlian
    Bi, Lei
    Ren, Yidan
    Song, Shuliang
    Wang, Qin
    Wang, Yun-shan
    MOLECULAR CANCER, 2018, 17
  • [50] Progresses in polymeric nanoparticles for delivery of tyrosine kinase inhibitors
    Foroughi-Nia, Behrouz
    Barar, Jaleh
    Memar, Mohammad Yousef
    Aghanejad, Ayuob
    Davaran, Soudabeh
    LIFE SCIENCES, 2021, 278
12345